SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-08-045478
Filing Date
2008-07-14
Accepted
2008-07-14 16:08:01
Documents
11
Period of Report
2008-07-14
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a08-18438_18k.htm 8-K 32014
2 EX-99.1 a08-18438_1ex99d1.htm EX-99.1 16296
3 EX-99.2 a08-18438_1ex99d2.htm EX-99.2 15308
4 EX-99.3 a08-18438_1ex99d3.htm EX-99.3 13108
5 GRAPHIC g184381mqi001.jpg GRAPHIC 40181
6 GRAPHIC g184381mqi002.jpg GRAPHIC 138218
7 GRAPHIC g184381mqi003.jpg GRAPHIC 50226
8 GRAPHIC g184381mqi004.jpg GRAPHIC 73859
9 GRAPHIC g184381mqi005.jpg GRAPHIC 56908
10 GRAPHIC g184381mqi006.jpg GRAPHIC 52674
11 GRAPHIC g184381mqi007.jpg GRAPHIC 33071
  Complete submission text file 0001104659-08-045478.txt   692652
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 08950904
SIC: 2834 Pharmaceutical Preparations